Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
38.8M
-
Shares change
-
+11.6M
-
Total reported value, excl. options
-
$168M
-
Value change
-
+$54.5M
-
Put/Call ratio
-
31.5
-
Number of buys
-
42
-
Number of sells
-
-20
-
Price
-
$4.33
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2015
73 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2015.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.8M shares
of 123M outstanding shares and own 31.48% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (7.57M shares), Point72 Asset Management, L.P. (6.57M shares), Consonance Capital Management LP (4.85M shares), Broadfin Capital, LLC (4.08M shares), FRANKLIN RESOURCES INC (2.51M shares), VANGUARD GROUP INC (2.23M shares), FEDERATED INVESTORS INC /PA/ (1.99M shares), PERCEPTIVE ADVISORS LLC (1.2M shares), SPHERA FUNDS MANAGEMENT LTD. (1.1M shares), and Catalyst Capital Advisors LLC (1.08M shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.